Drug Topics
Drug Topics is a unique news magazine that covers every aspect of pharmacy for community, independent, retail, and hospital pharmacists. Its main aim is to keep busy pharmacists updated and ready for the latest clinical, professional, business, legal, and governmental changes that impact their practices, all presented in a straightforward and digestible format. Besides offering valuable clinical insights for health-system pharmacists and those in both hospital and community environments, Drug Topics also provides essential business, financial, and regulatory guidance tailored for community pharmacists, whether they operate independently or as part of a chain.
Outlet metrics
Global
#579166
United States
#237726
Health/Pharmacy
#460
Articles
-
1 week ago |
drugtopics.com | Brian Nowosielski
Pharmacists exhibited successful capabilities of collaboration with other health care professionals in a primary care clinic, according to data published in the Canadian Pharmacists Journal.1 The researchers’ findings underscore the dynamic aspects of these relationships and pharmacists’ abilities in medication management. “Interprofessional care is endorsed by professionals and policymakers alike as the model for health service delivery in Canada,” wrote the authors.
-
1 week ago |
drugtopics.com | Brian Nowosielski
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines.1“Dermatological vaccines have emerged as critical tools in preventing and managing a wide spectrum of skin conditions ranging from infectious diseases to malignancies,” wrote the authors.
-
1 week ago |
drugtopics.com | Ashley Gallagher
The FDA approved dupilumab (Dupixent) for the treatment of bullous pemphigoid in adults.1 “Until now, treating bullous pemphigoid was very challenging for elderly patients struggling with the debilitating impact of blisters and lesions and potentially comorbid conditions,” Alyssa Johnsen, MD, PhD, global therapeutic area head of immunology and oncology development at Sanofi, said in a news release.1 “By addressing 2 central drivers of the underlying type 2 inflammation that contributes to...
-
1 week ago |
drugtopics.com | Brian Nowosielski
Through facilitation of social determinants of health (SDOH), human functioning, and rehabilitation, researchers support introducing “social dermatology” within the skin-care space, according to a study published in Acta Dermato-Venereologica.1“Increasing evidence supports the idea that SDOH, eg, educational attainment, employment, and community context, directly affect health status,” wrote authors of the study.
-
1 week ago |
drugtopics.com | Ashley Gallagher
In a new systematic review and meta-analysis, investigators found a positive association between cannabis use and major adverse cardiovascular events (MACE), raising awareness about the potential risks to cardiovascular health for cannabis users.1In an editorial published in Heart, the authors write that there has been frequent cannabis use increasing in several countries as many believe it is a safe and effective way to relieve pain despite evidence of health risks.
Drug Topics journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://drugtopics.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →